Dose-dependent dual effect of melatonin on ototoxicity induced by amikacin in adult rats

European Archives of Oto-Rhino-Laryngology

Volumn 262, Issue 4, 2005, Pages 314-321

  Erdem, Tamer ^a   Ozturan, Orhan ^a   Iraz, Mustafa ^a   Miman, Murat Cem ^a   Olmez, Ercument ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Amikacin; Distortion product otoacoustic emission; Melatonin; Ototoxicity; Prevention; Rat

Indexed keywords

AMIKACIN; ANTIOXIDANT; MELATONIN; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VASODILATATION;

AMIKACIN; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEARING LOSS; MELATONIN; OTOACOUSTIC EMISSIONS, SPONTANEOUS; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 18744393398     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-004-0793-1     Document Type: Article

References (50)

1. Aksoy N, Vural H, Sabuncu T, Aksoy S (2003) Effects of melatonin on oxidative-antioxidative status of tissues in streptozotocin-induced diabetic rats. Cell Biochem Funct 21:121-125
2. Anwar MM, Mahfouz HA, Sayed AS (1998) Potential protective effects of melatonin on bone marrow of rats exposed to cytotoxic drugs. Comp Biochem Physiol A Mol Integr Physiol 119:493-501
3. Anwar MM, Meki AR, Rahma HH (2001) Inhibitory effects of melatonin on vascular reactivity: possible role of vasoactive mediators. Comp Biochem Physiol Toxicol Pharmacol 130:357-367
4. Astbury PJ, Read NG (1982) Kanamycin-induced ototoxicity in the laboratory rat. Arch Toxicol 50:267-278
5. Basile AS, Huang JM, Xie C, Webster D, Berlin C, Skolnick P (1996) N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss. Nat Med 2:1338-1343
6. Benitez-King G, Anton-Tay F (1993) Calmodulin mediates melatonin cytoskeletal effects. Experientia 15:635-641
7. Benot S, Molinero P, Soutto M, Goberna R, Guerrero JM (1998) Circadian variations in the rat serum total antioxidant status: correlation with melatonin levels. J Pineal Res 25:1-4
8. Birau N, Pettersson U, Meyer C, Gottschalk J (1981) Hypotensive effect of melatonin in essential hypertension. IRCS. Med Sci Biochem 9:906
9. Cannacci A (1996) Melatonin in relation to physiology in adult humans. J Pineal Res 21:200-213
10. Cagnacci A, Arangino S, Angiolucci M, Maschio E, Melis GB (1998) Influences of melatonin administration on the circulation of women. Am J Physiol 274:335-338
11. Clerici WJ, Yang L ( 1996) Direct effects of intraperilymphatic reactive oxygen species generation on cochlear function. Hear Res 101:14-22
12. Conlon BJ, Aran JM, Erre JP, Smith DW (1999) Attenuation of aminoglycoside-induced cochlear damage with the metabolic antioxidant alpha-lipoic acid. Hear Res 128:40-44
13. Doolen S, Krause DN, Dubocovitch ML, Duckles SP (1998) Melatonin mediates two distinct responses in vascular smooth muscle. Eur J Pharmacol 345:67-69
14. Forge A, Schacht J (2000) Aminoglycoside antibiotics. Audiol Neurootol 5:3-22
15. Garetz SL, Altschuler RA, Schacht J (1994) Attenuation of gentamicin ototoxicity by gluthatione in the guinea pig in vivo. Hear Res 77:81-87
16. Geary GG, Krause DN, Duckles SP (1997) Melatonin directly constricts rat cerebral arteries through modulation of potassium channels. Am J Physiol 273:1530-1536
17. Henley CM, Weatherly RA, Ou CN, Brown RD (1996) Pharmacokinetics of kanamycin in the developing rat. Hear Res 99: 85-90
18. Hirose K, Hockenbery DM, Rubel EW (1997) Reactive oxygen species in chick hair cells after gentamicin exposure in vitro. Hear Res 104:1-14
19. Kawashima K, Miwa Y, Fujimoto K, Oohata H, Nishino H, Koike H (1987) Antihypertensive action of melatonin in the spontaneously hypertensive rat. Clin Exp Hypertens A 9:1121-1131
20. Lopez-Gonzalez MA, Guerrero JM, Delgado F (1997) Presence of the pineal hormone melatonin in rat cochlea: its variations with lighting conditions. Neurosci Lett 28:81-83
21. Lopez-Gonzalez MA, Delgado F, Lucas M (1999) Aminoglycosides activate oxygen metabolites production in the cochlea of mature and developing rats. Hear Res 136:165-168
22. Lopez-Gonzalez MA, Guerrero JM, Torronteras R, Osuna C, Delgado F (2000) Ototoxicity caused by aminoglycosides is ameliorated by melatonin without interfering with the antibiotic capacity of the drugs. J Pineal Res 28:26-33
23. Mahle CD, Goggins GD, Agarwal P, Ryan E, Watson AJ (1997) Melatonin modulates vascular smooth muscle tone. J Biol Rhythms 12:690-696
24. Masana MI, Doolen S, Ersahin C, Al-Ghoul WM, Duckles SP, Dubocowitch ML, Krause DN (2002) MT2 melatonin receptors are present and functionalin rat caudal artery. J Pharmacol Exp Ther 302:1295-1302
25. Miman MC, Ozturan O, Iraz M, Erdem T, Olmez E (2002) Amikacin ototoxicity enhanced by Ginkgo biloba extract (Egb 761). Hear Res 169:121-129
26. Morrey KM, McLachlan JA, Serkin CD, Bakouche O (1994) Activation of human monocytes by the pineal hormone melatonin. J Immunol 15:2671-2680
27. Nekrassov V, Sitges M (2000) Vinpocetine protects from aminoglycoside antibiotic-induced hearing loss in guinea pig in vivo. Brain Res 868:222-229
28. Okatani Y, Wakatsuki A, Watanabe K, Ikenoue N, Fukaya T (2000) Melatonin inhibits vasospastic action of oxidized low-density lipoprotein in human umbilical arteries. J Pineal Res 29:74-80
29. Priuska EM, Schacht J (1995) Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. Biochem Pharmacol 50:1749-1752
30. Provoost AP, Adejuyigbe O, Wolff ED (1985) Nephrotoxicity of aminoglycosides in young and adult rats. Pediatr Res 19:1191-1196
31. Reiter RJ, Tan DX, Cabrera J, D'Arpa D, Sainz RM, Mayo JC, Ramos S (1999) The oxidant/antioxidant network: role of melatonin, part I. Molecular biology biological signals and receptors 8:56-63
32. Sahna E, Olmez E, Acet A (2002) Effects of physiological and pharmacological concentrations of melatonin on ischemia-reperfusion arrhythmias in rats: can the incidence of sudden cardiac death be reduced? J Pineal Res 32:194-198
33. Satake N, Shibata S, Takagi T (1986) The inhibitory action of melatonin on the contractile response to 5-hydroxytryptamine in various isolated vascular smooth muscles. Gen Pharmacol 17:553-558
34. Satake N, Oe H, Shibata S (1991a) Vasorelaxing action of melatonin in rat isolated aorta; possible endothelium dependent relaxation. Gen Pharmacol 22:1127-1133
35. Satake N, Oe H, Sawada T, Shibata S (1991b) The mode of vasorelaxing action of melatonin in rabbit aorta. Gen Pharmacol 22:219-221
36. Sewerynek E (2002) Melatonin and the cardiovascular system. Neuroendocrinol Lett 23 [Suppl 1]:79-83
37. Sha SH, Schacht J (2000) Antioxidants attenuate gentamicin-induced free radical formation in vitro and ototoxicity in vivo: D-methionine is a potential protectant. Hear Res 142:34-40
38. Sharifzadeh M, Abdollahi M, Behrooz H, Minaii B, Kebriaeezadeh A, Kashani MR, Dehpour AR, Aghaebrahimi N (1998) Effects of chronic lithium on ototoxicity induced by gentamicin and amikacin in guinea pigs. Pharmacol Toxicol 83:220-224
39. Shibata S, Satake N, Takagi T, Usui H (1989) Vasorelaxing action of melatonin in rabbit basilar artery. Gen Pharmacol 20:677-680
40. Sullivan MJ, Rarey KE, Conolly RB (1987) Comparative ototoxicity of gentamicin in the guinea pig and two strains of rats. Hear Res 31:161-167
41. Takumida M, Popa R, Anniko M (1999) Free radicals in the guinea pig inner ear following gentamicin exposure. ORL J Otorhinolaryngol Relat Spec 61:63-70
42. Ting KN, Dunn WR, Davies DJ, Sugden D, Delagrange P, Guardiola-Lemaitre B, Scalbert E, Wilson VG (1997) Studies on the vasoconstrictor action of melatonin and putative melatonin receptor ligands in the tail artery of juvenile Wistar rats. Br J Pharmacol 122:1299-1306
43. Ting N, Thambyraja A, Sugden D, Scalbert E, Delagrange P, Wilson VG (2000) Pharmacological studies on the inhibitory action of melatonin and putative melatonin analogues on porcine vascular smooth muscle. Naunyn-Schmiedebergs Arch Pharmacol 361:327-333
44. Weekely LB (1991) Melatonin-induced relaxation of rat aorta: interaction with adrenergic agonists. J Pineal Res 11:28-34
45. Weekley LB (1993a) Effects of melatonin on pulmonary and coronary vessels are exerted through perivascular nerves. Clin Auton Res 3:45-47
46. Weekley LB (1993b) Effects of melatonin on isolated pulmonary artery and vein: role of vascular endothelium. Pulm Pharmacol 6:149-154
47. Weekley LB (1995) Pharmacologic studies on the mechanism of melatonin-induced vasorelaxation in rat aorta. J Pineal Res 19:133-138
48. Wright A, Forge A, Kotecha B (1997) Ototoxicity. In: Kerr AG (eds) Scott-Brown's otolaryngology. Butterworth-Heineman International Editions, Oxford, pp. 3/20/1-3/20/36
49. Wu L, Wang R, Champlain J de (1998) Enhanced inhibition by melatonin of alpha-adrenoceptor-induced aortic contraction and inositol phosphate production in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 16:339-347
50. Wu WJ, Sha SH, McLaren JD, Kawamoto K, Raphael Y, Schacht J (2001) Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague -Dawley rat. Hear Res 158:165-178